While an aberrant expression of P-cadherin associated with aggressive tumor behavior is observed in breast, gastric, endometrial, ovarian, prostate, pancreatic, bladder, and colorectal carcinomas [58], a common feature of the metastasis process is the loss of epithelial cadherin (E-cadherin). Here, CDH1 is linked to neoplasm.